BioCryst Pharmaceuticals | Despesa De Juros Sobre A Dívida

Interest Expense On Debt Alterar Data
Alnylam Pharmaceuticals USD 31.34M 445K 2023-12
Gilead Sciences USD 252M 20M 2023-12
Ionis Pharmaceuticals USD 4.56M 355K 2023-12
Neurocrine Biosciences USD 1.1M 200K 2023-09
Regeneron Pharmaceuticals USD 18.3M 500K 2023-12
Roche Holding CHF 401M 53M 2023-06
Sarepta Therapeutics USD 5.23M 5K 2023-09
Vertex Pharmaceuticals USD 10.9M 300K 2023-09



BioCryst Pharmaceuticals Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.